RT Journal Article
SR Electronic
T1 A precise measure of the impact of the first wave of Covid-19 on life expectancy. Regional differentials in Switzerland
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.19.20234716
DO 10.1101/2020.11.19.20234716
A1 Wanner, Philippe
YR 2020
UL http://medrxiv.org/content/early/2020/11/19/2020.11.19.20234716.abstract
AB Based on publicly available data supplied by the Swiss Federal Statistical Office (FSO), we calculated life tables by sex and by week for seven major regions of Switzerland in 2020, up to October 26th. These life tables provide information on the trends of life expectancy at birth and at the age of 65 years during the first wave of the coronavirus disease 2019 (COVID-19) epidemic.The results show a strong cyclical decrease in life expectancy, particularly in Ticino, where this variable has decreased by almost 6 years compared to the 2019 life expectancy, and in the Lake Geneva region. The other regions of Switzerland observed more modest decreases during the first wave, generally not exceeding a 2-year reduction. This decrease can be explained to some extent by seasonal variations in this indicator.In conclusion, the very sharp decrease in the average lifespan observed in the two regions mentioned above suggests that the first wave of the epidemic had a significant impact. It also reflects an unfavourable health situation. The life expectancy at the age of 65 years observed at the end of March 2020 in Ticino corresponded to the average life expectancy observed in Switzerland forty years ago.The calculated indicators have the advantage of accounting for the age structures of the respective populations. They therefore demonstrate their usefulness in monitoring during a pandemic, such as the one occurring currently.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was not funded by any grant. Manuscript preparation and statistical analyses were done as a part of the author's occupation at the University of GenevaAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical guidelines have been followed. The study is based on demographic data and does not need IRB approvalAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData that are used are available to the website of the Swiss Federal Statistical office (www.bfs.admin.ch). Data being subject to weekly revisions, a copy of the data downloaded on November 11, 2020 is available from the author at request